Home >  Investors Relations >  CryoLife Initiates Enrollment in PROACT Xa Clinical Trial

CryoLife to Participate in 20th Annual Needham Virtual Healthcare Conference

April 7, 2021 at 8:35 AM EDT

ATLANTA, April 7, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming 20th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021.  The Company's virtual fireside chat is scheduled to begin at 8:45 a.m. ET.  

A live webcast of the virtual fireside chat will be accessible through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website. 

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.  CryoLife markets and sells products in more than 100 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:

CryoLife

Gilmartin Group LLC

D. Ashley Lee     

Brian Johnston / Lynn Lewis

Executive Vice President, Chief Financial Officer

and Chief Operating Officer

Phone: 631-807-1986

Phone: 770-419-3355

investors@cryolife.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-to-participate-in-20th-annual-needham-virtual-healthcare-conference-301263812.html

SOURCE CryoLife, Inc.